M1A.40
Other secondary chronic gout, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary chronic gout, unspecified site (ICD-10 Code M1A.40), is a form of gout characterized by prolonged and persistent inflammation caused by the deposition of urate crystals in various tissues. Unlike acute gout attacks, this condition involves ongoing symptoms that can lead to joint damage and deformities over time. It often develops as a complication of other medical conditions or treatments that affect uric acid levels. Understanding this condition helps in managing its symptoms and preventing further joint deterioration.
Causes & Symptoms
Clinical Causes: Chronic kidney disease leading to decreased uric acid excretion Prolonged or untreated hyperuricemia (high uric acid levels in the blood) Use of medications like diuretics or aspirin that increase uric acid levels Metabolic disorders such as obesity and insulin resistance Certain genetic factors influencing uric acid metabolism Underlying health conditions such as leukemia or other blood disorders Prolonged dehydration or dehydration due to illness
Key Symptoms: Persistent joint pain, swelling, and tenderness Continuous inflammation around affected joints or tissues Presence of tophi (urate crystal deposits under the skin) Limited joint mobility due to deformities Repeated gout attacks leading to joint damage Possible skin ulceration over tophi In some cases, kidney stones caused by uric acid crystal accumulation
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary chronic gout involves a combination of clinical evaluation, laboratory tests, and imaging studies. Healthcare providers may perform the following:
Treatment Protocols: Managing other secondary chronic gout aims to control uric acid levels, reduce inflammation, and prevent joint damage. Typical approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M1A.40 a billable ICD-10 code?
Yes, M1A.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.40?
Clinical documentation must specify the nature of Other secondary chronic gout, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference